India's Bio-Economy Aims for $300 Billion Milestone: Union Minister
Click to start listening
Synopsis
India's bio-economy is on a path to reach $300 billion, growing from $10 billion in 2014 to nearly $130 billion now. Union Minister Dr. Jitendra Singh emphasizes the importance of genomic advancements in personalized medicine and the establishment of a genomic database to address unique health challenges.
Key Takeaways
- India's bio-economy aims for $300 billion milestone.
- Over 9,000 biotech startups exist now.
- Genomic advancements enable personalized medicine.
- AI-driven diagnostics improve treatment strategies.
- One million genome sequences will be completed.
Jammu, Feb 2 (NationPress) India’s bio-economy, which has expanded from $10 billion in 2014 to approximately $130 billion today, is setting its sights on a remarkable target of $300 billion in the near future, stated Union Minister Dr. Jitendra Singh on Sunday.
He also mentioned that the nation is home to over 9,000 biotech startups, a significant increase from just 50 in 2014, positioning India as a global frontrunner in medical innovation.
During the inauguration of the Centre for Advanced Genomics and Precision Medicine at AIIMS Jammu, the minister highlighted that advancements in genomics would enable healthcare professionals to move away from a one-size-fits-all treatment model, instead providing tailored therapies that optimize both effectiveness and specificity for individual patients.
Established in partnership with 4 base Care, the Centre aspires to launch a new chapter in personalized medicine by harnessing state-of-the-art genomic research to deliver targeted treatments based on unique genetic profiles.
By merging genomic information with AI-driven diagnostics, the Centre aims to improve early disease identification, refine treatment plans, and minimize the trial-and-error method often seen in medical prescriptions.
Experts at the event acknowledged that this facility would be crucial in advancing precision oncology, cardiovascular genomics, and genetic testing for rare conditions.
Dr. Singh noted that under the guidance of Prime Minister Narendra Modi, India has emphasized a technology-focused evolution in the healthcare domain.
The minister advocated for the development of a genomic database specific to India, underscoring the nation’s vast genetic diversity.
“India itself is a subcontinent, comprising over 4,600 distinct demographic groups. Our gene sequencing initiatives, which have already mapped 10,000 healthy individuals across 99 communities, will contribute to a solid dataset designed to address Indian-specific health challenges,” he stated.
The minister reaffirmed the government's dedication to completing one million genome sequences in the coming years to facilitate more precise disease forecasting and personalized treatment strategies.
Dr. Singh also highlighted the resurgence of infectious diseases alongside the increase in non-communicable diseases, advocating for a hybrid strategy that blends traditional diagnostics with genetic insights.
